Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in Canada for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and adults . The medication functions as a prodrug, meaning it’s inactive until metabolized by the body, providing dextroamphetamine slowly o… Read More